INDICATIONS AND USAGE
OMIDRIA is added to ophthalmic irrigation solution used during cataract surgery or intraocular lens
replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing
postoperative ocular pain.
IMPORTANT SAFETY INFORMATION
Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported
ocular adverse reactions at 2-24% are eye irritation, posterior capsule opacifi cation, increased intraocular
pressure, and anterior chamber infl ammation. OMIDRIA must be added to irrigation solution prior to use.
Use of OMIDRIA in children has not been established.
NOW AVAILABLE TO ORDER
IS THE TIME TO PREVENT INTRAOPERATIVE MIOSIS
AND REDUCE POSTOPERATIVE OCULAR PAIN
OMIDRIA
™
(phenylephrine and ketorolac injection)
1% / 0.3% is now available to order from your
wholesaler/distributor
Please see the Full Prescribing Information for
OMIDRIA at www.omidria.com/prescribinginformation.
Omeros
®
and the Omeros logo
®
are registered trademarks, and Omidria
™
and the Omidria logo
™
are trademarks, of Omeros Corporation. © Omeros Corporation 2015, all rights reserved. 2015-071
Visit Booth 417 to learn more
(phenylephrine and ketorolac injection)
Visit Booth 417 to learn more
